| Name | 2-chlorobenzyl 5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl sulfide |
|---|---|
| Synonyms |
Pyridine, 4-[5-[[(2-chlorophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]-
MFCD04031734 4-{5-[(2-Chlorobenzyl)sulfanyl]-1,3,4-oxadiazol-2-yl}pyridine |
| Description | GSK3-IN-1 (compound 11) is a GSK-3 inhibitor with an IC50 value of 12 μM. GSK3-IN-1 can be used in the research of diabetes[1]. |
|---|---|
| Related Catalog | |
| Target |
GSK-3[1] |
| References |
| Density | 1.43±0.1 g/cm3(Predicted) |
|---|---|
| Boiling Point | 492.2±55.0 °C(Predicted) |
| Molecular Formula | C14H10ClN3OS |
| Molecular Weight | 303.767 |
| Flash Point | 251.5±31.5 °C |
| Exact Mass | 303.023315 |
| LogP | 4.10 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.673 |